US Patent Issued to TREEWAY TW001 on July 29 for "Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders" (Dutch Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,139, issued on July 29, was assigned to TREEWAY TW001 B.V. (Rotterdam, Netherlands).

"Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders" was invented by Ronald Van Der Geest (Rotterdam, Netherlands) and Sytske Hyke Moolenaar (Rotterdam, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of a liquid aqueous solution of edaravone in the treatment of an oxidative stress-mediated neurodegenerative disorder in a human patient, said treatment comprising at least once daily oral administration of the liquid edaravone solution to the human patient, to provide a daily ...